Interestingly, Frohlich et al. also reported that the oncolytic vector T-VEC showed the potential for synergistic anti-cancer effects to overcome the resistance of mucosal melanoma to ICI anti PD-1 [90]. The gene discussed is PDCD1; the disease is mucosal melanoma.